F
The startup develops a drug discovery screening system that targets ferroptosis and oxidized lipids using first-in-class low-molecular-weight drugs. This platform enables physicians to understand variations in drug efficacy among patients, enhancing the drug development process and improving treatment outcomes in ophthalmic, neurological, and neonatal applications.
Updated 2 months ago
Funding
$2.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a drug discovery screening system that targets ferroptosis and oxidized lipids using first-in-class low-molecular-weight drugs. This platform enables physicians to understand variations in drug efficacy among patients, enhancing the drug development process and improving treatment outcomes in ophthalmic, neurological, and neonatal applications.